Intratympanic gentamicin for Ménière's disease or syndrome.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 21412917)

Published in Cochrane Database Syst Rev on March 16, 2011

Authors

Bas Pullens1, Peter Paul van Benthem

Author Affiliations

1: ENT Surgery, University Medical Centre Utrecht, Heidelberglaan 100, Utrecht, Netherlands, 3584 CX.

Articles citing this

The treatment and natural course of peripheral and central vertigo. Dtsch Arztebl Int (2013) 3.38

MR volumetric assessment of endolymphatic hydrops. Eur Radiol (2014) 0.88

Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS One (2012) 0.87

Clinical Subgroups in Bilateral Meniere Disease. Front Neurol (2016) 0.85

Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière's Disease: Case Report and Review of the Literature. Case Rep Otolaryngol (2013) 0.84

Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ (2016) 0.83

Gentamicin concentration gradients in scala tympani perilymph following systemic applications. Audiol Neurootol (2013) 0.79

Protective effect of metformin on gentamicin-induced vestibulotoxicity in rat primary cell culture. Clin Exp Otorhinolaryngol (2014) 0.78

Chemical labyrinthectomy for the worse ear of adult Nigerians with bilateral Meniere's disease: preliminary report of treatment outcomes. Eur Arch Otorhinolaryngol (2014) 0.77

Intratympanic gentamicin treatment 'as needed' for Meniere's disease. Long-term analysis using the Kaplan-Meier method. Eur Arch Otorhinolaryngol (2013) 0.77

Leupeptin reduces impulse noise induced hearing loss. J Occup Med Toxicol (2011) 0.77

Intratympanic gentamicin treatment for Ménière's disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study. Trials (2014) 0.76

Vestibular results after intratympanic gentamicin therapy in disabling Menière's disease. Eur Arch Otorhinolaryngol (2016) 0.76

In reply. Dtsch Arztebl Int (2013) 0.75

Interventions for Menière's disease: protocol for an umbrella systematic review and a network meta-analysis. BMJ Open (2016) 0.75

[Dizziness from the viewpoint of otorhinolaryngology]. Ophthalmologe (2013) 0.75

Is gentamycin delivery via sustained-release vehicles a safe and effective treatment for refractory Meniere's disease? A critical analysis of published interventional studies. Eur Arch Otorhinolaryngol (2016) 0.75

Hydrogen Inhalation Protects against Ototoxicity Induced by Intravenous Cisplatin in the Guinea Pig. Front Cell Neurosci (2017) 0.75